Literature DB >> 33669751

Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue.

Michele Ammendola1, Giuseppe Currò1, Carmelo Laface2,3, Valeria Zuccalà4, Riccardo Memeo5, Francesco Luposella6, Mariarita Laforgia7, Nicola Zizzo8, Alfredo Zito9, Donato Loisi9, Rosa Patruno8, Lucia Milella1, Ippazio Ugenti1,5, Mariangela Porcelli2, Giuseppe Navarra10, Cosmo Damiano Gadaleta2, Girolamo Ranieri2.   

Abstract

BACKGROUND: Mast cells (MCs) contain proangiogenic factors, in particular tryptase, associated with increased angiogenesis in several tumours. With special reference to pancreatic cancer, few data have been published on the role of MCs in angiogenesis in both pancreatic ductal adenocarcinoma tissue (PDAT) and adjacent normal tissue (ANT). In this study, density of mast cells positive for c-Kit receptor (MCDP-c-KitR), density of mast cells positive for tryptase (MCDPT), area of mast cells positive for tryptase (MCAPT), and angiogenesis in terms of microvascular density (MVD) and endothelial area (EA) were evaluated in a total of 45 PDAT patients with stage T2-3N0-1M0.
RESULTS: For each analysed tissue parameter, the mean ± standard deviation was evaluated in both PDAT and ANT and differences were evaluated by Student's t-test (p ranged from 0.001 to 0.005). Each analysed tissue parameter was then correlated to each other one by Pearson t-test analysis (p ranged from 0.01 to 0.03). No other correlation among MCDP-c-KitR, MCDPT, MCAPT, MVD, EA and the main clinical-pathological characteristics was found.
CONCLUSIONS: Our results suggest that tissue parameters increased from ANT to PDAT and that mast cells are strongly associated with angiogenesis in PDAT. On this basis, the inhibition of MCs through tyrosine kinase inhibitors, such as masitinib, or inhibition of tryptase by gabexate mesylate may become potential novel antiangiogenetic approaches in pancreatic cancer therapy.

Entities:  

Keywords:  adjacent normal tissue; angiogenesis; c-Kit receptor; endothelial area; mast cells; microvascular density; pancreatic cancer tissue; tryptase

Year:  2021        PMID: 33669751     DOI: 10.3390/cells10020444

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  4 in total

1.  A Patient With Stage III Locally Advanced Pancreatic Adenocarcinoma Treated With Intra-Arterial Infusion FOLFIRINOX: Impressive Tumoral Response and Death due to Legionella pneumophila Infection: A Unique Case Report.

Authors:  Girolamo Ranieri; Sara Sablone; Vito Fazio; Dario De Ceglia; Mariangela Porcelli; Pasquale Molinari; Livia Fucci; Carmelo Laface; Cosmo Damiano Gadaleta
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

Review 2.  Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities.

Authors:  Carmelo Laface; Palma Fedele; Felicia Maria Maselli; Francesca Ambrogio; Caterina Foti; Pasquale Molinari; Michele Ammendola; Marco Lioce; Girolamo Ranieri
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

Review 3.  Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion.

Authors:  Xuejun Shao; Shenghao Hua; Tao Feng; Dickson Kofi Wiredu Ocansey; Lei Yin
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 4.  Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review.

Authors:  Carmelo Laface; Mariarita Laforgia; Pasquale Molinari; Caterina Foti; Francesca Ambrogio; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.